These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 5011759)

  • 41. Monocyte chemotaxis and chemotactic cytokine release after exposure to hydroxyethyl starch.
    Eastlund DT; Douglas MS; Choper JZ
    Transfusion; 1992; 32(9):855-60. PubMed ID: 1281943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3.
    Youn BS; Zhang SM; Lee EK; Park DH; Broxmeyer HE; Murphy PM; Locati M; Pease JE; Kim KK; Antol K; Kwon BS
    J Immunol; 1997 Dec; 159(11):5201-5. PubMed ID: 9548457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring leukocyte traffic in vivo into human delayed-type hypersensitivity reaction.
    Savilahti E; Kirveskari J; Järvinen A; Tervo T; Renkonen R
    J Immunol Methods; 2004 May; 288(1-2):81-9. PubMed ID: 15183087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemotaxis of human monocyte-derived dendritic cells to complement component C1q is mediated by the receptors gC1qR and cC1qR.
    Vegh Z; Kew RR; Gruber BL; Ghebrehiwet B
    Mol Immunol; 2006 Mar; 43(9):1402-7. PubMed ID: 16140380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human monocyte-derived chemotactic factor for granulocytes.
    Tono-Oka T; Nakayama M; Matsumoto S
    Immunology; 1980 Apr; 39(4):607-13. PubMed ID: 6991401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Inhibitory effect on rabbit peritoneal leukocyte and macrophage chemotaxis by sera from patients with pulmonary sarcoidosis: significance of serum chemotactic inhibitor in sarcoidosis].
    Okuyama Y
    Hokkaido Igaku Zasshi; 1982 Mar; 57(2):197-209. PubMed ID: 7118051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defective monocyte chemotaxis in pulmonary tuberculosis.
    Nielsen H; Bennedsen J; Larsen SO; Rhodes JM; Viskum K
    Eur J Respir Dis; 1982 Mar; 63(2):122-9. PubMed ID: 7067763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison between results of leukocyte migration inhibition test and skin hypersensitivity of tuberculin in man].
    Claudy A; Thivolet J; Valancogne A; Schmitt D
    Rev Eur Etud Clin Biol; 1971 Oct; 16(8):826-30. PubMed ID: 5128513
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cellular immunity in allergic diseases].
    Kupchinskas IuK; Shmigel'skene NI
    Klin Med (Mosk); 1971 Mar; 49(3):23-6. PubMed ID: 5562411
    [No Abstract]   [Full Text] [Related]  

  • 50. [Studies on mechanisms of tuberculin hypersensitivity. I. The relation between the functions of cells mediating tuberculin-type hypersensitivity (TTH) and the infiltrating cells in skin reaction site (author's transl)].
    Oyamaguchi A
    Kekkaku; 1982 Feb; 57(2):59-71. PubMed ID: 7040775
    [No Abstract]   [Full Text] [Related]  

  • 51. Transfer factor in vitro. Additional data concerning a new method.
    Arala-Chaves M; Ramos MT; Rosado R; Branco P
    Int Arch Allergy Appl Immunol; 1974; 46(4):612-8. PubMed ID: 4819302
    [No Abstract]   [Full Text] [Related]  

  • 52. A role for humoral factors in psoriasis.
    Krueger GG; Chambers DA; Stubbs JD; Jederberg WW; Torres AR
    J Lab Clin Med; 1982 Feb; 99(2):275-87. PubMed ID: 7061921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A quantitative high-throughput chemotaxis assay using bioluminescent reporter cells.
    Vishwanath RP; Brown CE; Wagner JR; Meechoovet HB; Naranjo A; Wright CL; Olivares S; Qian D; Cooper LJ; Jensen MC
    J Immunol Methods; 2005 Jul; 302(1-2):78-89. PubMed ID: 15987642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A case of impaired chemotaxis and lymphocyte transformation.
    Hass RJ; Niethammer D; Flad HD; Wildfeuer A; Bültmann B; Haferkamp O; Kleihauer E
    Acta Paediatr Scand; 1976 Mar; 65(2):241-7. PubMed ID: 1258638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Delayed type hypersensitivity in vitro. 2. Inhibition of the antigen against migration of cells in vitro capable of transferring tuberculin hypersensitivity].
    Yoshida T; Watanuki M
    Igaku To Seibutsugaku; 1968 Oct; 77(4):131-7. PubMed ID: 5751543
    [No Abstract]   [Full Text] [Related]  

  • 56. [Effect of serum from tuberculous patients on lymphocyte blastic transformation in sarcoidosis].
    Girard JP; Poupon MF; Press P; Favez G
    Schweiz Med Wochenschr; 1970 Nov; 100(46):1986-8. PubMed ID: 5507845
    [No Abstract]   [Full Text] [Related]  

  • 57. Production of chemotactic activity by guinea pig immunoglobulins following activation of the C3 complement shunt pathway.
    Sandberg AL; Snyderman R; Frank MM; Osler AG
    J Immunol; 1972 May; 108(5):1227-31. PubMed ID: 5029138
    [No Abstract]   [Full Text] [Related]  

  • 58. Leukotaxis and leukotactic disorders. A review.
    Ward PA
    Am J Pathol; 1974 Dec; 77(3):520-38. PubMed ID: 4611227
    [No Abstract]   [Full Text] [Related]  

  • 59. Fractionation of human leukocyte extracts transferring delayed hypersensitivity to tuberculin.
    Arala-Chaves MP; Lebacq EG; Heremans JF
    Int Arch Allergy Appl Immunol; 1967; 31(4):353-65. PubMed ID: 6034730
    [No Abstract]   [Full Text] [Related]  

  • 60. Cytology of tuberculin reaction.
    Müftüoğlu AU; Akman N; Başar I
    Acta Haematol; 1971; 46(2):121-8. PubMed ID: 5001571
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.